Search

everythinglearnresearchcommunity

for

Search:↓

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Monitoring for adverse effects in clinical treatments is crucial.

Japan improved its regulation of regenerative medicine to ensure safety and prevent unproven treatments.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

Treating epilepsy is complex, requiring careful drug choice and patient adherence to manage seizures and side effects.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Conductive hydrogels show promise for medical uses like healing wounds and tissue regeneration but need improvements in safety and stability.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Valproic acid can cause muscle damage and liver issues, which improve after stopping the drug.

Finasteride may help treat hidradenitis suppurativa in children, but concerns exist about ethics, safety, and proper use.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Clascoterone is safe for the heart, even at high doses.

Europe needs a clear system to watch over cosmetics for safety and to make sure product claims are true.